Investigating mechanisms of aggressive glioblastoma tumor growth

by Olivia Dimmer,Northwestern UniversitySchematic representation of the role of the LDHA–ERK–STAT3/YAP pathway in regulation of CCL2 and CCL7 in glioblastoma cells, which, in turn, promotes macr

Updated on: March 30,2024

Investigating mechanisms of aggressive glioblastoma tumor growth

by Olivia Dimmer,Northwestern UniversitySchematic representation of the role of the LDHA–ERK–STAT3/YAP pathway in regulation of CCL2 and CCL7 in glioblastoma cells, which, in turn, promotes macr

Updated on:March 30,2024

Prostate cancer drug given initial 'no' for NHS in England

by Cancer Research UKCredit: Cancer Research UKA prostate cancer drug has been provisionally rejected as a first-line treatment on the NHS in England.The draft recommendation from the National In

Updated on: May 11,2024

Prostate cancer drug given initial 'no' for NHS in England

by Cancer Research UKCredit: Cancer Research UKA prostate cancer drug has been provisionally rejected as a first-line treatment on the NHS in England.The draft recommendation from the National In

Updated on:May 11,2024

Fighting aggressive blood cancer ages and exhausts immune cells, study shows

byNottingham Trent UniversityGraphical abstract. Credit:Journal of Clinical Investigation(2022). DOI: 10.1172/JCI159579Scientists at Nottingham Trent University and John Hopkins Kimm

Updated on: January 22,2024

Fighting aggressive blood cancer ages and exhausts immune cells, study shows

byNottingham Trent UniversityGraphical abstract. Credit:Journal of Clinical Investigation(2022). DOI: 10.1172/JCI159579Scientists at Nottingham Trent University and John Hopkins Kimm

Updated on:January 22,2024

New cell death mechanism could offer novel cancer treatment strategies

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Pixabay/CC0 Public DomainA study from researchers at The University of Texas MD Anderson Cancer Center, published today inNature C

Updated on: January 12,2024

New cell death mechanism could offer novel cancer treatment strategies

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Pixabay/CC0 Public DomainA study from researchers at The University of Texas MD Anderson Cancer Center, published today inNature C

Updated on:January 12,2024

New major survey finds 'healthy' suntan myths persist despite warnings about skin cancer and aging

by European Academy of Dermatology and VenereologyCredit: CC0 Public DomainAmong Europeans, 8 in 10 believe tans are attractive, with almost as many (73%) saying tans are healthy, according to a new s

Updated on: February 01,2024

New major survey finds 'healthy' suntan myths persist despite warnings about skin cancer and aging

by European Academy of Dermatology and VenereologyCredit: CC0 Public DomainAmong Europeans, 8 in 10 believe tans are attractive, with almost as many (73%) saying tans are healthy, according to a new s

Updated on:February 01,2024

New study highlights rapid adoption of clinical research results into chemotherapy prescribing patterns

by National Comprehensive Cancer NetworkCredit: Pixabay/CC0 Public DomainNew research inJNCCN—Journal of the National Comprehensive Cancer Networkevaluates how an important analysis on loc

Updated on: February 01,2024

New study highlights rapid adoption of clinical research results into chemotherapy prescribing patterns

by National Comprehensive Cancer NetworkCredit: Pixabay/CC0 Public DomainNew research inJNCCN—Journal of the National Comprehensive Cancer Networkevaluates how an important analysis on loc

Updated on:February 01,2024

A new hope in immunotherapy against cancer

by Karolinska InstitutetIdentification of SB02024 as a potent and selective inhibitor of VPS34. (A) Chemical structure of SB02024. (B) Cartoon representation of the structure of complex between V

Updated on: April 06,2024

A new hope in immunotherapy against cancer

by Karolinska InstitutetIdentification of SB02024 as a potent and selective inhibitor of VPS34. (A) Chemical structure of SB02024. (B) Cartoon representation of the structure of complex between V

Updated on:April 06,2024

Looking for cancer information: Can ChatGPT be counted on?

by Huntsman Cancer InstituteCredit: Pixabay/CC0 Public DomainAstudyin theJournal of The National Cancer Institute Cancer Spectrumlooked at chatbots and artificial intelligence

Updated on: January 15,2024

Looking for cancer information: Can ChatGPT be counted on?

by Huntsman Cancer InstituteCredit: Pixabay/CC0 Public DomainAstudyin theJournal of The National Cancer Institute Cancer Spectrumlooked at chatbots and artificial intelligence

Updated on:January 15,2024

ASH: A+AVD beats ABVD for advanced Hodgkin's lymphoma

(HealthDay)—For patients with advanced-stage Hodgkin's lymphoma, brentuximab vedotin, doxorubicin, vinblastine, and dacarbazine (A+AVD) have superior efficacy to doxorubicin, bleomycin, vinblastin

Updated on: March 30,2024

ASH: A+AVD beats ABVD for advanced Hodgkin's lymphoma

(HealthDay)—For patients with advanced-stage Hodgkin's lymphoma, brentuximab vedotin, doxorubicin, vinblastine, and dacarbazine (A+AVD) have superior efficacy to doxorubicin, bleomycin, vinblastin

Updated on:March 30,2024

Breakthrough research makes cancer-fighting viral agent more effective

byAarhus University4-OI promotes VSVΔ51 infection and oncolysis. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-48422-xWhen a cancer cell doesn't respond to traditio

Updated on: July 08,2024

Breakthrough research makes cancer-fighting viral agent more effective

byAarhus University4-OI promotes VSVΔ51 infection and oncolysis. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-48422-xWhen a cancer cell doesn't respond to traditio

Updated on:July 08,2024

Study sheds new light on mechanism of breast cancer treatment resistance

by Dana-Farber Cancer InstituteMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainA study by researchers at Dana-Farber Cancer Institute has illumina

Updated on: March 01,2024

Study sheds new light on mechanism of breast cancer treatment resistance

by Dana-Farber Cancer InstituteMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainA study by researchers at Dana-Farber Cancer Institute has illumina

Updated on:March 01,2024

Study: Value of chemotherapy post immunotherapy in stage IV non-small cell lung cancer

by Impact Journals LLCResponse to docetaxel in second or third line treatment for non-small cell lung cancer after a treatment with chemo-immunotherapy. Credit:Oncotarget(2023). DOI: 10.18

Updated on: January 30,2024

Study: Value of chemotherapy post immunotherapy in stage IV non-small cell lung cancer

by Impact Journals LLCResponse to docetaxel in second or third line treatment for non-small cell lung cancer after a treatment with chemo-immunotherapy. Credit:Oncotarget(2023). DOI: 10.18

Updated on:January 30,2024